Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2025-12-25 @ 11:57 PM
Study NCT ID:
NCT00805194
Status:
COMPLETED
Last Update Posted:
2018-12-05
First Post:
2008-12-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung Cancer
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-12-03
Start Date Type:
ACTUAL
Primary Completion Date:
2010-11-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-11-13
Completion Date Type:
ACTUAL
First Submit Date:
2008-12-08
First Submit QC Date:
None
Study First Post Date:
2008-12-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-11-14
Results First Submit QC Date:
None
Results First Post Date:
2014-12-01
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-11-09
Last Update Post Date:
2018-12-05
Last Update Post Date Type:
ACTUAL